Researchers at Oregon State University have observed that frequent cannabis users begin each morning with cortisol levels already elevated above those of non-users — a quiet but meaningful disruption to the body's daily stress rhythm. The finding is not a condemnation but a complication: stress relief is among the most common reasons people turn to cannabis, yet the drug may gradually reshape the very biology it is meant to soothe. Science cannot yet say whether cannabis causes this pattern or whether more stress-prone individuals simply use it more often, but the question itself carries weigh
Cannabis users show elevated morning cortisol, raising questions about stress system disruption
Cobertura Relacionada
Research reveals water content has a non-linear effect on coal spontaneous combustion, with optimal moisture at 6.15% ma…
Space Daily · Aug 20 Galileo's 58-minute Jupiter plunge remains our only direct atmospheric sampleNASA's 1995 Galileo probe remains humanity's only direct atmospheric sample of Jupiter after 58 minutes of transmission.…
Mirage News · Aug 20 August Nectar Shortage Threatens Honeybees, Study FindsUniversity of Sussex research reveals honeybees struggle most to forage for nectar in August due to fewer blooming flowe…
Spatial Source · Aug 20 Bathymetry maps reveal ancient landscapes where First Nations lived before Great Barrier Reef submersionAustralian researchers used advanced bathymetric mapping to reveal submerged landscapes where First Nations people lived…
Sesgo y Encuadre
No hay datos de análisis detallado para esta lente. Intenta volver a ejecutar las lentes desde el panel de administración.
Impacto Geopolítico
This is a health/medical research article about cannabis and cortisol levels, not a geopolitical issue.
Lente Económico
Cannabis research reveals elevated cortisol in frequent users, potentially disrupting stress systems and creating dependency loops, with implications for healthcare costs and pharmaceutical markets.
Consumers may face increased healthcare costs if cannabis use correlates with stress-related conditions and diabetes complications. Those using cannabis for stress management may experience reduced efficacy or adverse metabolic effects, potentially increasing medical expenses. Health insurance premiums could rise if cannabis-related health complications become prevalent.
Potential regulatory tightening on cannabis marketing claims regarding stress relief and relaxation benefits. Healthcare systems may need to develop screening protocols for cannabis users with diabetes or stress disorders. Public health campaigns may shift messaging around cannabis use. Insurance policies may adjust coverage or pricing based on cannabis use disclosure. Pharmaceutical companies may face pressure to develop alternative stress management treatments.